Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Ben Stadelmann
Fonar CorpFONRWATCHSep 06, 2005
Sells MRI machines to the health care industry. They're in a good niche. Have a specific technology that seems to be gaining acceptance. Reasonably well managed. Have registered for selling up to 10 million shares, but doesn't mean they will. This may be what is holding them back. Will take a few more quarters to see where they are heading.
Ben StadelmannUnknown
$1.09
Stock price when the opinion was issued
$19.11
As of Jun 02, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
DON'T BUY
An MRI company and they do a stand-up MRI. Have leading edge technology with numerous patents. Afraid that management lives in a bit of a fantasy world and think they’re God's gift to MRIs. There aren't enough companies buying their product. They lose money almost every year.
biotechnologypharmaceutical
DON'T BUY
Manufacture a stand-up MRI, the only one in the business. There is a good chance it will be de-listed by the end of January. Have a good product but they have difficulty making money.
Benj GallanderOwned
biotechnologypharmaceutical
